05.23.26 -- Addressing Readiness Gaps Before Technology Adoption

Happy Saturday! This weekend’s editorial focus is on data quality and infrastructure and how these underscore technology adoption.

In a recent guest column, BioPhorum’s Ciera Clayton emphasizes the importance of organizational readiness in technology adoption, specifically, as it relates to manufacturing execution systems (MES). Advanced technological capabilities are great, but they aren’t magical cure-alls for an organization. “Focusing solely on advanced capabilities without addressing people, process, and governance challenges increases the likelihood of stalled initiatives and unrealized benefits,” writes Clayton.

Steve Gens expresses a similar sentiment in his guest column on regulatory information management (RIM) systems, noting that, “Modernization and readiness are not the same thing.” Building your modern tech stack on immature processes and broken data infrastructure is like building a house on a cardboard foundation.

Proper data governance and infrastructure are critical when it comes to adopting new technology — especially AI. In this guest column with Gourav Pandey, a quality lead at Takeda, he describes a multi-agent audit intelligence framework built for CDMO audit preparation and explains the quality safeguards underpinning this multi-agent system.

Before you go, be sure to check out some selected content from our partners below!

Tyler Menichiello                      
Chief Editor, Bioprocess Online

FUJIFILM Biotechnologies shares how a standardized approach can remove bottlenecks, accelerate technology transfer, and build supply chain resilience.

Middlesex County, NJ, is rapidly becoming an epicenter — where investment, talent, and infrastructure converge to accelerate discovery and fuel long‑term growth.

Honeywell explores how digital procedures and eLogbooks replace paper with real-time accuracy, audit-ready data, and faster manufacturing. Make the shift now.

QIAGEN showcases a rapid approach to detecting mycoplasma contamination, helping biopharma teams strengthen quality control and confidently protect advanced therapies.

IDBS discusses operational clarity in modern labs, which reduces rework, strengthens data integrity, and builds confidence to close gaps and move faster.

Körber helps pharma leaders approach Pharma 4.0 with confidence, offering modular, interoperable digitization that delivers efficiency, compliance, and real-world impact.

MasterControl uncovers how AI is reshaping quality management, outlining practical benefits, adoption challenges, and why forward-thinking organizations should act now.